In The News,
ADVI director Lindsay Bealor Greenleaf talks changes to drug rebates and PBMs with the Washington Post
[el-text]
Written by Paulina Firozi
***excerpt***
Lindsay Bealor Greenleaf, director at health-care consulting firm ADVI, said it’s clear Express Scripts is responding to pressure from policymakers.
“This announcement aligns with the direction things are headed in Washington — of policymakers rethinking the role played by rebates,” Greenleaf said. “This is a proactive step to get prepared for a new environment that will change up their business.”
***end excerpt***
***
[/el-text]